A major development is unfolding in the healthcare technology sector, and it's a story that will leave you wanting more. The future of patient records is at stake, and a billion-pound deal is on the horizon.
American private equity firm TPG is on the brink of acquiring the company behind the electronic patient record system used by most British GPs. Sky News has revealed that TPG has reached an agreement in principle to buy Optum's UK operations, owned by the New York-listed healthcare giant UnitedHealth Group.
Sources indicate that the deal, expected to be announced soon, could be valued at a staggering £1.2bn to £1.4bn. However, there's a catch - it's not yet finalized, and there's always a chance it could fall through.
But here's where it gets controversial... If the deal goes through, it will mark just two years since the business last changed hands. One source suggests that TPG might look to merge Optum UK with Nextech, a US-based provider of electronic medical record software for doctors' practices.
Optum UK's portfolio includes EMIS, which UnitedHealth acquired in 2023 for around £1.2bn. The takeover was masterminded by Sir Andrew Witty, the former GlaxoSmithKline CEO who has since stepped down as UnitedHealth's chief executive.
The US-listed company's stock has taken a hit, dropping by a third over the last year, leaving its market capitalization at just under $310bn on Tuesday. Bank of America has been advising on the sale, which also attracted interest from buyout firms like Blackstone.
The prospective sale is part of an effort by Sir Andrew's successor, Stephen Hemsley, to halt the company's worrying decline in valuation. Optum's acquisition of EMIS was approved by British competition regulators in September 2023 after an extensive Phase 2 investigation.
TPG and Optum have declined to comment on the matter.
This story is a reminder of the ever-shifting landscape of healthcare technology and the potential impact on patient data and services. It's a complex issue with many moving parts, and we'd love to hear your thoughts. Do you think these mergers and acquisitions are beneficial for the healthcare industry? Or do they raise concerns about data privacy and control? Let us know in the comments!
